Condition: Diabetes · Type 2 Diabetes · Type 2 Diabetes Mellitus - Poor Control · Sponsor: Yale University
This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.
This description comes directly from the study's public registry record.
Justin A Dower, MD · (973) 901-4431 · justin.dower@yale.edu
Anne Camp, MD · (203) 927-6666 · a.camp@fhchc.org
Always discuss trial participation with your own doctor first.
| Fair Haven Community Health Care (FHCHC) | New Haven, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06658067